Fiche centre
John Hunter Hospital
New Lambton Heights — Australia
Essais liés3clinical trials
VilleNew Lambton Heightslocalisation
PaysAustralialocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT07064473
Essais cliniques associés
3| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| Vicadrostat | Hypertension | Phase 3 | NCT07064473 | EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease | RECRUITING |
| CNM-Au8 | SEP | Phase 2/3 | NCT04626921 | VISIONMS-LTE — A Multi-Center, Open-Label Long-Term Extension Study of CNM-Au8 In Patients With Stable Relapsing Multiple Sclerosis | COMPLETED |
| CNM-Au8 | SEP | Phase 2 | NCT03536559 | VISIONARY-MS — Nanocrystalline Gold to Treat Remyelination Failure in Chronic Optic Neuropathy In Multiple Sclerosis | TERMINATED |